Alliance Wealth Advisors LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 33.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 791 shares of the healthcare conglomerate’s stock after selling 401 shares during the period. Alliance Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $403,000 at the end of the most recent reporting period.
Other large investors have also recently bought and sold shares of the company. Outfitter Financial LLC bought a new position in UnitedHealth Group during the fourth quarter valued at approximately $25,000. Blue Bell Private Wealth Management LLC bought a new position in UnitedHealth Group during the fourth quarter valued at approximately $29,000. Advocacy Wealth Management Services LLC lifted its position in UnitedHealth Group by 75.8% during the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 25 shares during the period. Cascade Investment Advisors Inc. lifted its position in UnitedHealth Group by 100.0% during the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 30 shares during the period. Finally, Tortoise Investment Management LLC lifted its position in UnitedHealth Group by 54.8% during the fourth quarter. Tortoise Investment Management LLC now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 23 shares during the period. Hedge funds and other institutional investors own 87.48% of the company’s stock.
Shares of NYSE:UNH opened at $489.68 on Thursday. The company has a market capitalization of $459.40 billion, a price-to-earnings ratio of 26.80, a PEG ratio of 1.41 and a beta of 0.83. UnitedHealth Group Incorporated has a 12 month low of $383.12 and a 12 month high of $553.29. The firm’s 50-day moving average is $496.56 and its 200 day moving average is $490.86. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.54.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 28th. Shareholders of record on Monday, June 20th will be given a $1.65 dividend. This represents a $6.60 annualized dividend and a yield of 1.35%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.45. The ex-dividend date of this dividend is Thursday, June 16th. UnitedHealth Group’s payout ratio is 36.12%.
In related news, Director Richard T. Burke sold 2,500 shares of the stock in a transaction that occurred on Thursday, May 19th. The shares were sold at an average price of $478.96, for a total transaction of $1,197,400.00. Following the completion of the sale, the director now owns 1,215,000 shares of the company’s stock, valued at $581,936,400. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Frederick William Mcnabb III bought 89 shares of the firm’s stock in a transaction that occurred on Thursday, May 26th. The shares were purchased at an average cost of $504.32 per share, with a total value of $44,884.48. Following the transaction, the director now directly owns 11,259 shares of the company’s stock, valued at $5,678,138.88. The disclosure for this purchase can be found here. 0.40% of the stock is currently owned by corporate insiders.
UNH has been the topic of several recent research reports. Royal Bank of Canada set a $563.00 price target on shares of UnitedHealth Group and gave the stock an “outperform” rating in a research report on Monday, April 18th. Loop Capital assumed coverage on shares of UnitedHealth Group in a research report on Thursday, June 16th. They set a “buy” rating and a $575.00 price objective on the stock. Barclays raised their price objective on shares of UnitedHealth Group from $495.00 to $565.00 and gave the company an “overweight” rating in a research report on Wednesday, March 30th. SVB Leerink raised their price objective on shares of UnitedHealth Group from $550.00 to $600.00 and gave the company an “outperform” rating in a research report on Tuesday, April 19th. Finally, Truist Financial raised their price objective on shares of UnitedHealth Group from $575.00 to $610.00 in a research report on Thursday, April 7th. Three research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $555.73.
About UnitedHealth Group (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Downturn Gives These 3 Buys Juicy Dividend Yields
- Victoria’s Secret Stock is Out of the Box
- Time For a Ride in Six Flags Stock
- Why Dollar General (NYSE: DG) Should Be In Your Portfolio
- Korn Ferry Is A Good Buy For The Recession And Beyond
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.